NDC 85237-1886-07 - ADVIL DUAL ACTION WITH ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1886
- Requested NDC
- 85237-1886-07
- Package NDCs from labels
- 85237-1886-0, 85237-1886-1, 85237-1886-2, 85237-1886-7, 85237-1886-4, 85237-1886-6, 85237-1886-07
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-07-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ADVIL DUAL ACTION WITH ACETAMINOPHEN - Select Consumer Group | Select Consumer Group | 2026-07-04 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 | |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Childrens TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 3a935584-6045-0a58-e063-6394a90a40c4 | 2025-07-23 | Warnings | 362O9ITL9D |
| DR. SANA PAIN AND FEVER FOR Children | ACETAMINOPHEN | GADAL Laboratories, Inc | 8a22a5ba-8623-4cca-8723-52b495403461 | 2025-07-23 | Warnings | 362O9ITL9D |
| Childrens Ibuprofen | IBUPROFEN | Publix Super Markets Inc | 54ae0273-4d8d-4c3b-85ff-675ba96f00de | 2025-07-22 | Warnings | WK2XYI10QM |
| OXYCODONE AND ACETAMINOPHEN | OXYCODONE AND ACETAMINOPHEN | Direct_Rx | 90a11364-fc42-e94e-e053-2a95a90a9782 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Defensol D | ACETAMINOPHEN, CHLORPHERINAMINE MALEATE, PHENYLEPHRINE HCI | Menper Distributors, Inc. | f466c660-69eb-4581-81ff-1499fa421d8b | 2025-07-22 | Warnings | 362O9ITL9D |
| Defensol D Blister Pack | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCI | Menper Distributors, Inc. | 0dfcc977-6101-4536-e063-6294a90a7a48 | 2025-07-22 | Warnings | 362O9ITL9D |
| Duralgina | ACETAMINOPHEN | Menper Distributors Inc. | bb31f66c-80a9-4bdb-983b-cef5d21de5ff | 2025-07-22 | Warnings | 362O9ITL9D |
| ADVIL SINUS CONGESTION AND PAIN | IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | b1e29c19-fe03-4d2b-b966-0adf4eb4b4cf | 2025-07-22 | Warnings | WK2XYI10QM |
| Gesteira | ACETAMINOPHEN | Menper Distributors, Inc. | 5a907289-564c-491b-98d5-d7f43eaaa1b2 | 2025-07-22 | Warnings | 362O9ITL9D |
| Extra strength Acetaminophen PM | ACETAMINOPHEN 500MG/ DIPHENHYDRAMINE HCL 25MG | TIME CAP LABS INC | 010c5c98-fc67-a9c3-e063-6394a90aa640 | 2025-07-21 | Warnings | 362O9ITL9D |
| La Defense Broad Spectrum SPF 30 Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Luzern Laboratories, Inc | 3f00befa-415d-415d-89e1-6ba8770ba51e | 2025-07-21 | Warnings | 15FIX9V2JP |
| INFANTS IBUPROFEN | IBUPROFEN | Safeway | 6fed7c65-69a3-4899-a85d-23ea95f571a4 | 2025-07-21 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | SOLA Pharmaceuticals, LLC | 44fb0842-c34e-477e-96df-350cd5d6800e | 2025-07-20 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Chain Drug Consortium | 6c593a9c-680e-4645-8e8f-d8d044c92ca1 | 2025-07-18 | Warnings | WK2XYI10QM |
| Dual Action | ACETAMINOPHEN AND IBUPROFEN (NSAID) TABLETS, 250 MG/ 125 MG | Dr. Reddy's Laboratories Inc | c8a8a18a-6766-37a9-d0f0-f9380fb5b0e8 | 2025-07-18 | Warnings | 2387532 WK2XYI10QM 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.